Growth Metrics

Resmed (RMD) Accounts Payables (2016 - 2025)

Resmed's Accounts Payables history spans 16 years, with the latest figure at $250.4 million for Q4 2025.

  • For Q4 2025, Accounts Payables rose 13.66% year-over-year to $250.4 million; the TTM value through Dec 2025 reached $250.4 million, up 13.66%, while the annual FY2025 figure was $278.2 million, 17.01% up from the prior year.
  • Accounts Payables reached $250.4 million in Q4 2025 per RMD's latest filing, down from $266.8 million in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $278.2 million in Q2 2025 to a low of $117.2 million in Q1 2021.
  • Average Accounts Payables over 5 years is $193.7 million, with a median of $179.5 million recorded in 2022.
  • Peak YoY movement for Accounts Payables: fell 5.33% in 2023, then skyrocketed 57.69% in 2024.
  • A 5-year view of Accounts Payables shows it stood at $163.4 million in 2021, then increased by 19.98% to $196.0 million in 2022, then rose by 3.26% to $202.4 million in 2023, then increased by 8.85% to $220.3 million in 2024, then rose by 13.66% to $250.4 million in 2025.
  • Per Business Quant, the three most recent readings for RMD's Accounts Payables are $250.4 million (Q4 2025), $266.8 million (Q3 2025), and $278.2 million (Q2 2025).